Is the viability of your business dependent on any regulatory factors related to the status of psychedelic medicines, neurotech, or healthcare (e.g. changes to drug scheduling, FDA approvals, etc.)? If so, tell us your approach to dealing with that. If not, tell us how or why your business is insulated from broader psychedelics or neurotech regulatory policy.